These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 17555529)

  • 1. Coxiella burnetii infection in C57BL/6 mice aged 1 or 14 months.
    Leone M; Bechah Y; Meghari S; Lepidi H; Capo C; Raoult D; Mege JL
    FEMS Immunol Med Microbiol; 2007 Aug; 50(3):396-400. PubMed ID: 17555529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vanin-1 controls granuloma formation and macrophage polarization in Coxiella burnetii infection.
    Meghari S; Berruyer C; Lepidi H; Galland F; Naquet P; Mege JL
    Eur J Immunol; 2007 Jan; 37(1):24-32. PubMed ID: 17163446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TLR2 is necessary to inflammatory response in Coxiella burnetii infection.
    Meghari S; Honstettre A; Lepidi H; Ryffel B; Raoult D; Mege JL
    Ann N Y Acad Sci; 2005 Dec; 1063():161-6. PubMed ID: 16481508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microbicidal property of B1 cell derived mononuclear phagocyte.
    Popi AF; Zamboni DS; Mortara RA; Mariano M
    Immunobiology; 2009; 214(8):664-73. PubMed ID: 19321225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of sex on Coxiella burnetii infection: protective role of 17beta-estradiol.
    Leone M; Honstettre A; Lepidi H; Capo C; Bayard F; Raoult D; Mege JL
    J Infect Dis; 2004 Jan; 189(2):339-45. PubMed ID: 14722900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of cyclophosphamide on Coxiella burnetii infection in mice.
    Kazár J; Rajcáni J; Schramek S
    Acta Virol; 1982 May; 26(3):174-82. PubMed ID: 6127018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative virulence of phase I and II Coxiella burnetii in immunodeficient mice.
    Andoh M; Russell-Lodrigue KE; Zhang G; Samuel JE
    Ann N Y Acad Sci; 2005 Dec; 1063():167-70. PubMed ID: 16481509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role for the CD28 molecule in the control of Coxiella burnetii infection.
    Honstettre A; Meghari S; Nunès JA; Lepidi H; Raoult D; Olive D; Mege JL
    Infect Immun; 2006 Mar; 74(3):1800-8. PubMed ID: 16495554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipopolysaccharide from Coxiella burnetii is involved in bacterial phagocytosis, filamentous actin reorganization, and inflammatory responses through Toll-like receptor 4.
    Honstettre A; Ghigo E; Moynault A; Capo C; Toman R; Akira S; Takeuchi O; Lepidi H; Raoult D; Mege JL
    J Immunol; 2004 Mar; 172(6):3695-703. PubMed ID: 15004173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of B cells in host defense against primary Coxiella burnetii infection.
    Schoenlaub L; Elliott A; Freches D; Mitchell WJ; Zhang G
    Infect Immun; 2015 Dec; 83(12):4826-36. PubMed ID: 26438792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistent Coxiella burnetii infection in mice overexpressing IL-10: an efficient model for chronic Q fever pathogenesis.
    Meghari S; Bechah Y; Capo C; Lepidi H; Raoult D; Murray PJ; Mege JL
    PLoS Pathog; 2008 Feb; 4(2):e23. PubMed ID: 18248094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induced production of nitric oxide and sensitivity of alveolar macrophages derived from mice with different sensitivity to Coxiella burnetii.
    Yoshiie K; Matayoshi S; Fujimura T; Maeno N; Oda H
    Acta Virol; 1999 Oct; 43(5):273-8. PubMed ID: 10757226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-response model of Coxiella burnetii (Q fever).
    Tamrakar SB; Haluska A; Haas CN; Bartrand TA
    Risk Anal; 2011 Jan; 31(1):120-8. PubMed ID: 20723147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracellular life of Coxiella burnetii in macrophages.
    Ghigo E; Pretat L; Desnues B; Capo C; Raoult D; Mege JL
    Ann N Y Acad Sci; 2009 May; 1166():55-66. PubMed ID: 19538264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Balb/c mouse model and real-time quantitative polymerase chain reaction for evaluation of the immunoprotectivity against Q fever.
    Zhang J; Wen B; Chen M; Zhang J; Niu D
    Ann N Y Acad Sci; 2005 Dec; 1063():171-5. PubMed ID: 16481510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Failure of Q fever phase I corpuscular vaccine to influence the persistence and reactivation of Coxiella burnetii infection in mouse and guinea pig tissues.
    Kazár J; Kovácová E
    Acta Virol; 1983 Sep; 27(5):418-28. PubMed ID: 6139946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attenuated Coxiella burnetii phase II causes a febrile response in gamma interferon knockout and Toll-like receptor 2 knockout mice and protects against reinfection.
    Ochoa-Repáraz J; Sentissi J; Trunkle T; Riccardi C; Pascual DW
    Infect Immun; 2007 Dec; 75(12):5845-58. PubMed ID: 17893129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Link between impaired maturation of phagosomes and defective Coxiella burnetii killing in patients with chronic Q fever.
    Ghigo E; Honstettre A; Capo C; Gorvel JP; Raoult D; Mege JL
    J Infect Dis; 2004 Nov; 190(10):1767-72. PubMed ID: 15499532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coxiella burnetii, the agent of Q fever, stimulates an atypical M2 activation program in human macrophages.
    Benoit M; Barbarat B; Bernard A; Olive D; Mege JL
    Eur J Immunol; 2008 Apr; 38(4):1065-70. PubMed ID: 18350541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coxiella burnetii: host and bacterial responses to infection.
    Waag DM
    Vaccine; 2007 Oct; 25(42):7288-95. PubMed ID: 17825460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.